title: Microevolutionary events involving narrow host plasmids influences local fixation of vancomycin-resistance in Enterococcus populations.
abstract: Vancomycin-resistance in enterococci (VRE) is associated with isolates within ST18, ST17, ST78 Enterococcus faecium (Efm) and ST6 Enterococcus faecalis (Efs) human adapted lineages. Despite of its global spread, vancomycin resistance rates in enterococcal populations greatly vary temporally and geographically. Portugal is one of the European countries where Tn1546 (vanA) is consistently found in a variety of environments. A comprehensive multi-hierarchical analysis of VRE isolates (75 Efm and 29 Efs) from Portuguese hospitals and aquatic surroundings (1996-2008) was performed to clarify the local dynamics of VRE. Clonal relatedness was established by PFGE and MLST while plasmid characterization comprised the analysis of known relaxases, rep initiator proteins and toxin-antitoxin systems (TA) by PCR-based typing schemes, RFLP comparison, hybridization and sequencing. Tn1546 variants were characterized by PCR overlapping/sequencing. Intra- and inter-hospital dissemination of Efm ST18, ST132 and ST280 and Efs ST6 clones, carrying rolling-circle (pEFNP1/pRI1) and theta-replicating (pCIZ2-like, Inc18, pHTβ-like, two pRUM-variants, pLG1-like, and pheromone-responsive) plasmids was documented. Tn1546 variants, mostly containing ISEf1 or IS1216, were located on plasmids (30-150 kb) with a high degree of mosaicism and heterogeneous RFLP patterns that seem to have resulted from the interplay between broad host Inc18 plasmids (pIP501, pRE25, pEF1), and narrow host RepA_N plasmids (pRUM, pAD1-like). TAs of Inc18 (ω-ε-ζ) and pRUM (Axe-Txe) plasmids were infrequently detected. Some plasmid chimeras were persistently recovered over years from different clonal lineages. This work represents the first multi-hierarchical analysis of VRE, revealing a frequent recombinatorial diversification of a limited number of interacting clonal backgrounds, plasmids and transposons at local scale. These interactions provide a continuous process of parapatric clonalization driving a full exploration of the local adaptive landscape, which might assure long-term maintenance of resistant clones and eventually fixation of Tn1546 in particular geographic areas.
authors.affiliation: REQUIMTE, Laboratório de Microbiologia, Faculdade de Farmácia, Universidade do Porto, Porto, Portugal.
authors.forename: Ana R
authors.initials: AR
authors.lastname: Freitas
authors.forename: Carla
authors.initials: C
authors.lastname: Novais
authors.forename: Ana P
authors.initials: AP
authors.lastname: Tedim
authors.forename: María Victoria
authors.initials: MV
authors.lastname: Francia
authors.forename: Fernando
authors.initials: F
authors.lastname: Baquero
authors.forename: Luísa
authors.initials: L
authors.lastname: Peixe
authors.forename: Teresa M
authors.initials: TM
authors.lastname: Coque
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D004251:DNA Transposable Elements; D004269:DNA, Bacterial / Q000235:genetics; D016984:Enterococcus faecium / Q000187:drug effects* / Q000235:genetics / Q000302:isolation & purification; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D008969:Molecular Sequence Data; D010957:Plasmids / Q000235:genetics; D011174:Portugal / Q000453:epidemiology; D014640:Vancomycin / Q000494:pharmacology*; D020713:Vancomycin Resistance
chemical_list: D000900:Anti-Bacterial Agents; D004251:DNA Transposable Elements; D004269:DNA, Bacterial; D014640:Vancomycin
references.citation: Antimicrob Agents Chemother. 2010 Jun;54(6):2660-5
references.pmid: 20385861
references.citation: Nat Med. 2012 May;18(5):816-9
references.pmid: 22522561
references.citation: Int J Med Microbiol. 2011 Feb;301(2):165-75
references.pmid: 20951641
references.citation: Science. 2003 Mar 28;299(5615):2071-4
references.pmid: 12663927
references.citation: FEMS Microbiol Rev. 2009 May;33(3):657-87
references.pmid: 19396961
references.citation: J Clin Microbiol. 2004 Oct;42(10):4473-9
references.pmid: 15472296
references.citation: Plasmid. 2009 Mar;61(2):94-109
references.pmid: 19100285
references.citation: J Antimicrob Chemother. 2011 Dec;66(12):2685-8
references.pmid: 21948966
references.citation: Microb Drug Resist. 2012 Apr;18(2):183-8
references.pmid: 22257297
references.citation: Microbiology (Reading). 2011 Feb;157(Pt 2):387-397
references.pmid: 21030436
references.citation: Proc Natl Acad Sci U S A. 2010 Jul 6;107(27):12269-74
references.pmid: 20566881
references.citation: Appl Environ Microbiol. 2005 Jun;71(6):3364-8
references.pmid: 15933043
references.citation: Microb Drug Resist. 1999 Summer;5(2):113-29
references.pmid: 10432272
references.citation: J Antimicrob Chemother. 2010 Sep;65(9):1894-906
references.pmid: 20558469
references.citation: J Clin Microbiol. 2011 Mar;49(3):925-31
references.pmid: 21227995
references.citation: Future Microbiol. 2009 Nov;4(9):1125-35
references.pmid: 19895216
references.citation: J Clin Microbiol. 2007 Sep;45(9):2813-8
references.pmid: 17634295
references.citation: J Antimicrob Chemother. 2012 Apr;67(4):832-6
references.pmid: 22228676
references.citation: Plasmid. 2001 Nov;46(3):170-87
references.pmid: 11735367
references.citation: Plasmid. 2008 Jul;60(1):75-85
references.pmid: 18511120
references.citation: Appl Environ Microbiol. 2006 Jan;72(1):516-21
references.pmid: 16391086
references.citation: FEMS Immunol Med Microbiol. 2010 Mar;58(2):254-68
references.pmid: 20015231
references.citation: N Engl J Med. 2000 Mar 9;342(10):710-21
references.pmid: 10706902
references.citation: Mol Biol Evol. 2012 Apr;29(4):1225-40
references.pmid: 22130968
references.citation: J Clin Microbiol. 2005 Apr;43(4):1575-80
references.pmid: 15814968
references.citation: J Clin Microbiol. 2002 Sep;40(9):3326-33
references.pmid: 12202574
references.citation: Lancet. 2005 Apr 2-8;365(9466):1256-8
references.pmid: 15811459
references.citation: J Clin Microbiol. 2000 Sep;38(9):3317-22
references.pmid: 10970377
references.citation: Anal Biochem. 1995 Apr 10;226(2):235-40
references.pmid: 7793624
references.citation: Euro Surveill. 2008 Nov 20;13(47):
references.pmid: 19021959
references.citation: PLoS One. 2012;7(2):e30319
references.pmid: 22363425
references.citation: Appl Environ Microbiol. 2009 Jul;75(14):4904-8
references.pmid: 19447948
references.citation: Plasmid. 2007 Mar;57(2):175-81
references.pmid: 16893567
references.citation: J Clin Microbiol. 1999 Apr;37(4):1084-91
references.pmid: 10074530
references.citation: mBio. 2012 Feb 21;3(1):
references.pmid: 22354957
references.citation: Antimicrob Agents Chemother. 1999 Mar;43(3):483-91
references.pmid: 10049255
references.citation: Science. 2011 Sep 23;333(6050):1764-7
references.pmid: 21940899
references.citation: J Bacteriol. 1993 Jan;175(1):117-27
references.pmid: 8380148
references.citation: Antimicrob Agents Chemother. 1998 Mar;42(3):502-8
references.pmid: 9517923
references.citation: Microb Drug Resist. 2011 Sep;17(3):357-61
references.pmid: 21563953
references.citation: Lancet Infect Dis. 2009 Jun;9(6):357-64
references.pmid: 19467475
references.citation: Mol Microbiol. 2003 Mar;47(6):1733-47
references.pmid: 12622825
references.citation: J Infect Dis. 2009 Nov 15;200(10):1566-73
references.pmid: 19821720
references.citation: Nat Rev Microbiol. 2009 Sep;7(9):629-41
references.pmid: 19680247
references.citation: Eur J Clin Microbiol Infect Dis. 2009 Jul;28(7):855-9
references.pmid: 19184139
references.citation: Antimicrob Agents Chemother. 2001 Mar;45(3):986-9
references.pmid: 11181398
references.citation: J Bacteriol. 1981 Mar;145(3):1365-73
references.pmid: 7009583
references.citation: Foodborne Pathog Dis. 2011 Nov;8(11):1191-7
references.pmid: 21793656
references.citation: mBio. 2012 Jul 17;3(4):e00151-12
references.pmid: 22807567
references.citation: Theor Popul Biol. 2009 Sep;76(2):105-17
references.pmid: 19464307
references.citation: Proc Natl Acad Sci U S A. 1974 Jul;71(7):2744-7
references.pmid: 4527752
references.citation: FEMS Microbiol Rev. 2011 Sep;35(5):872-900
references.pmid: 21658083
references.citation: Mol Microbiol. 2003 Mar;47(5):1419-32
references.pmid: 12603745
references.citation: Lancet Infect Dis. 2001 Dec;1(5):314-25
references.pmid: 11871804
references.citation: Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):311-6
references.pmid: 17190821
references.citation: Antimicrob Agents Chemother. 1995 Nov;39(11):2446-53
references.pmid: 8585724
references.citation: PLoS One. 2007 Jul 04;2(7):e582
references.pmid: 17611618
references.citation: Curr Opin Microbiol. 2006 Oct;9(5):454-60
references.pmid: 16880002
references.citation: J Antimicrob Chemother. 2008 Oct;62(4):681-7
references.pmid: 18583326
references.citation: Antimicrob Agents Chemother. 2007 Feb;51(2):736-9
references.pmid: 17116680
references.citation: Nat Med. 2003 Apr;9(4):424-30
references.pmid: 12627227
references.citation: Front Microbiol. 2013 Mar 06;4:15
references.pmid: 23508522
references.citation: Antimicrob Agents Chemother. 2010 Oct;54(10):4314-20
references.pmid: 20660665
references.citation: Proc Natl Acad Sci U S A. 2009 Jun 16;106 Suppl 1:9939-46
references.pmid: 19528641
references.citation: Curr Microbiol. 2009 Feb;58(2):95-100
references.pmid: 18830745
references.citation: J Clin Microbiol. 1995 Sep;33(9):2233-9
references.pmid: 7494007
references.citation: J Antimicrob Chemother. 2009 Jun;63(6):1104-11
references.pmid: 19329507
references.citation: J Clin Microbiol. 1998 Nov;36(11):3303-8
references.pmid: 9774583
references.citation: Infect Control Hosp Epidemiol. 1998 Aug;19(8):539-45
references.pmid: 9758052
references.citation: Antimicrob Agents Chemother. 2008 Mar;52(3):1001-8
references.pmid: 18180362
references.citation: J Microbiol Methods. 2010 Jan;80(1):25-43
references.pmid: 19879906
references.citation: Antimicrob Agents Chemother. 2005 Jul;49(7):3073-9
references.pmid: 15980404